Please login to the form below

Not currently logged in
Email:
Password:

FTC

This page shows the latest FTC news and features for those working in and with pharma, biotech and healthcare.

Merck’s $11.5bn acquisition of Acceleron delayed

Merck’s $11.5bn acquisition of Acceleron delayed

Merck withdrew its Premerger Notification and Report Form, filed on 14 October, to give the Federal Trade Commission (FTC) additional time for review. ... The refiling allows anti-competition regulators at the FTC more time to review the offer and gives

Latest news

More from news
Approximately 8 fully matching, plus 52 partially matching documents found.

Latest Intelligence

  • Will biosimilars ever catch on in the US? Will biosimilars ever catch on in the US?

    FTC. According to Michael A Carrier, a distinguished professor at Rutgers Law School, “the FTC has played a leading role in challenging ‘pay for delay’ settlements for two decades”. ... The FTC has also made legal arguments against the practice

  • Innovation in merger control and the impact on the pharmaceutical sector Innovation in merger control and the impact on the pharmaceutical sector

    In the US, the Federal Trade Commission (FTC) has followed a similar approach. ... The FTC challenged the merger, alleging harm to innovation and to future price competition.

  • Pharma deals in May 2015 Pharma deals in May 2015

    The product has been the subject of an investigation from the US Federal Trade Commission (FTC) and although not usually reported in Deal Watch, the $1.2bn settlement is noteworthy recognising ... This is not the first such case for Teva, as the FTC also

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....